Default: Critical Reviews in Oncology/Hematology

ISSN: 1040-8428

Journal Home

Journal Guideline

Critical Reviews in Oncology/Hematology Q1 Unclaimed

Elsevier Ireland Ltd Ireland
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Critical Reviews in Oncology/Hematology is a journal indexed in SJR in Hematology and Oncology with an H index of 122. It has an SJR impact factor of 2,084 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,084.

Critical Reviews in Oncology/Hematology focuses its scope in these topics and keywords: cancer, treatment, relapsed, review, systematic, radiotherapy, role, immunity, il, hematopoietic, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Critical Reviews in Oncology/Hematology

2,084

SJR Impact factor

122

H Index

188

Total Docs (Last Year)

542

Total Docs (3 years)

15644

Total Refs

3437

Total Cites (3 years)

539

Citable Docs (3 years)

5,69

Cites/Doc (2 years)

83,21

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, treatment, relapsed, review, systematic, radiotherapy, role, immunity, il, hematopoietic, future, overviewstudying, metastatic, models, molecules, multiple, myelomaa, options, existing, elderly, antiangiogenic, asparaginase, based, basic, bone, carcinoma, cell, challenges, childhood, class, clinical, concomitant, cytokinesvinflunine,



Best articles by citations

Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma

View more

The role of adjuvant chemotherapy in the treatment of adult soft tissue sarcomas

View more

The cellular biology of B-cell chronic lymphocytic leukemia

View more

Phosphofructokinase: A mediator of glycolytic flux in cancer progression

View more

Autologous spheroid culture: a screening tool for human brain tumour invasion

View more

Rules allowing the reimbursement of cares of elderly cancer patients in France

View more

The role of cytokines in the normal and neoplastic pituitary

View more

Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature

View more

Cytoskeletal and adhesion protein changes during neoplastic progression of human prostate epithelial cells

View more

Contribution of three-dimensional culture to cancer research

View more

Prostate cancer incidence and mortality trends among elderly and adult Europeans

View more

The treatment of undifferentiated neuroendocrine tumors

View more
SHOW MORE ARTICLES

Benign breast disease and cancer risk

View more

Important issues in planning and conducting multi-centre randomised trials in cancer and publishing their results

View more

Prescribers' attitudes toward elderly breast cancer patients. Discrimination or empathy?

View more

Incidence of cancer after immunosuppressive treatment for heart transplantation

View more

Management of bone metastases in cancer: A review

View more

Clinical benefits of stabilisation with second line chemotherapy in patients with metastatic colorectal cancer

View more

Timing of breast cancer surgery in relation to the menstrual cycle: an update of developments

View more

The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer

View more

Direct intratumoral chemotherapy

View more

Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators

View more

Economic evaluations of systemic adjuvant breast cancer treatments: methodological issues and a critical review

View more

Microinvasive squamous cell cervical carcinoma

View more

FAQS